Abstract 580P
Background
Primary tumor location (PTL) is a well-established prognostic factor in stage III and IV colorectal cancer (CRC), with right-sided CRC (RSCC) showing a worse prognosis compared to left-sided CRC (LSCC). However, the impact of PTL on stage II CRC remains uncertain. One explanation for these inconsistencies is the potential confounding effect of molecular biomarkers, such as MMR status. Therefore, there is a need to elucidate the prognostic value of PTL, as well as the role of biomarkers in this effect.
Methods
This study utilized observational data from a retrospective cohort obtained from the Belgian Cancer Registry (BCR). The study population comprised all patients diagnosed with pathologically confirmed stage II CRC in Belgium from January 1st, 2015, to December 31st, 2016 (n= 3,278). Information on PTL, demographics, pathologic T category (pT category), and molecular biomarkers (including MMR status, BRAF and KRAS mutations) was collected from the registry, along with vital status to calculate overall survival (OS). The primary aim of this study was to investigate the independent prognostic value of PTL in stage II CRC. Additionally, we assessed whether potential confounding factors, such as biomarkers and demographics, influenced the prognostic effect of PTL.
Results
In the univariate analysis, patients with stage II RSCC had a significantly worse OS compared to those with LSCC (including rectal cancer; p-value=0.0055 and excluding rectal cancer; p-value=0.0035). Higher age and pT4 were also significantly associated with worse OS. However, in the multivariable analysis, only gender, age, and pathologic T-stage were found to be significant predictors of OS. PTL was not a significant factor in multivariable analysis. Furthermore, biomarkers such as MMR-status, BRAF-, and KRAS mutations did not show a significant effect on OS in either analysis.
Conclusions
Our analysis led us to the conclusion that PTL is not an independent prognostic factor in stage II. Notably, we observed confounding effects between patient characteristics and the prognostic impact of PTL, such as older age at diagnosis and shorter OS in patients with RSCC. Furthermore, molecular biomarkers did not have a statistically significant effect on OS in stage II CRC.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
University of Antwerp.
Funding
Antwerp University Hospital.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
581P - The effect of exercise intervention on defecation related symptoms of colorectal cancer patients a randomized controlled trial
Presenter: Justin Jeon
Session: Poster session 10
582P - High accuracy of a blood-based multimodal ctDNA test to detect advanced neoplasms in a FIT-positive screening population
Presenter: Joana Vidal Barrull
Session: Poster session 10
583P - A rapid blood test for the earlier detection of colorectal cancer
Presenter: Jennifer Nobes
Session: Poster session 10
584P - Two-year update of the prospective evaluation of ColonAiQ (PreC) study
Presenter: Yanbing Ding
Session: Poster session 10
585P - Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer
Presenter: Yuepeng Cao
Session: Poster session 10
586P - Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
Presenter: Daphne Day
Session: Poster session 10
588P - PLCRC-PROVENC3 study: Prognostic value of post-surgery liquid biopsy circulating tumor DNA in stage III colon cancer patients
Presenter: Carmen Rubio-Alarcón
Session: Poster session 10
589P - Impact of landmark point selection on molecular residual disease detection in stage I-IV resectable colorectal cancer
Presenter: Di Cao
Session: Poster session 10
590P - Assessment of circulating tumor (ct)DNA in patients (pts) with locally advanced rectal cancer (LARC) pts treated with neoadjuvant therapy (NAT)
Presenter: Chiara Molinari
Session: Poster session 10